Research guide · Metabolic Support
5-Amino-1MQ — research protocol
Small molecule NNMT inhibitor studied for metabolic and adipose tissue studies.
This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.
Catalog presentations
Concentration table
Mathematical reference only; this is not a dosing recommendation.
Research areas
- NNMT inhibitor
- Metabolic studies
- Lyophilized stability
Most-cited research protocols
Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.
5-Amino-1MQ is a small molecule studied for its potential to shrink fat cells and raise NAD+ levels by blocking the NNMT enzyme. It is primarily used in research contexts and is not FDA-approved.
| Dose | Frequency | Duration | Route | |
|---|---|---|---|---|
| Oral (start low) | 50 mg | once daily | Weeks 1–2 | Oral capsule |
| Oral (standard) | 100 mg | once daily | Weeks 3+ | Oral capsule |
| Oral (split option) | 50 mg + 50 mg | morning + midday | Weeks 3+ | Oral capsule |
| Subcutaneous (standard) | 5 mg | once daily | Days 3+ | Subcutaneous |
Cycle: 8 to 12 weeks on, then 4 to 6 weeks off
Benefits and research observations: Morning dosing is common; sleep, energy, and digestion changes are frequently monitored. Liver enzyme monitoring and a baseline ALT/AST check are recommended.
Handling and storage
Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.
Warnings
Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.
Published sources
- 1.Neelakantan H, et al. Biochem Pharmacol, 2018.
- 2.Kraus D, et al. Nature, 2014.